Nalpropion Pharmaceuticals - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Nalpropion Pharmaceuticals M&A Summary

Nalpropion Pharmaceuticals has acquired 1 company of its own.

Nalpropion Pharmaceuticals’ largest acquisition to date was in 2018, when it acquired OREXIGEN Therapeutics for $75M. Nalpropion Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Nalpropion Pharmaceuticals Ownership

Who owns Nalpropion Pharmaceuticals?

Nalpropion Pharmaceuticals is owned by Currax Pharmaceuticals. It was acquired on September 27, 2019.

Nalpropion Pharmaceuticals Business Overview

Where is Nalpropion Pharmaceuticals headquartered?

Nalpropion Pharmaceuticals is headquartered in San Diego, California.

What sector is Nalpropion Pharmaceuticals in?

Nalpropion Pharmaceuticals is a life science company.

When was Nalpropion Pharmaceuticals founded?

Nalpropion Pharmaceuticals was founded in 2018.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

Nalpropion Pharmaceuticals, Inc.

9171 Towne Centre Drive, Suite 270,
San Diego, California 92122
United States,
(858) 875-8600
www.nalpropion.com

Nalpropion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the treatment of weight loss. Nalpropion Pharmaceuticals was formed in 2018 and is based in San Diego, California.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
vol $75M $75M
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
OREXIGEN Therapeutics, Inc. 2018-04-24 75M USD Special Situations/Distressed
La Jolla, California · www.orexigen.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 75M (100%) - -
Total 1 $75M - -

By Geo

State/Country Buy Value Sell Value
United States 1 75M - -
  California 1 75M - -
Total 1 $75M - -

Deal Values

buy # Total
< $100M 1 $75M
TOTAL $75M
Largest OREXIGEN Therapeutics, Inc.
$75M (2018-04-24)

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.